Skip to main content
. 2017 Mar 17;8(18):30190–30198. doi: 10.18632/oncotarget.16318

Table 6. Breast cancer molecular subtypes between LN(−) and LN(+) tumors.

Characteristics LN (−) LN (+) P value
Molecular subtypes (N = 389) 0.013
 Luminal A 46 (21.8) 22 (12.4)
 Luminal B 93 (44.1) 104 (58.4)
 HER2 52 (24.6) 42 (23.6)
 Basal 20 (9.5) 10 (5.6)
Luminal A vs. others (N = 389) 0.015
 Yes 46 (21.8) 22 (12.4)
 No 165 (78.2) 156 (87.6)
Luminal B vs. others (N = 389) 0.005
 Yes 93 (44.1) 104 (58.4)
 No 118 (55.9) 74 (41.6)
HER2 vs. others (N = 389) 0.810
 Yes 52 (24.6) 42 (23.6)
 No 159 (75.4) 136 (76.4)
Basal vs. others (N = 389) 0.155
 Yes 20 (9.5) 10 (5.6)
 No 191 (90.5) 168 (94.4)
Luminal A vs. Luminal B (N = 265) 0.004
 Luminal A 46 (33.1) 22 (17.5)
 Luminal B 93 (66.9) 104 (82.5)
Luminal A vs. HER2 (N = 162) 0.113
 Luminal A 46 (46.9) 22 (34.4)
 HER2 52 (53.1) 42 (65.6)
Luminal A vs. Basal (N = 98) 0.924
 Luminal A 46 (69.7) 22 (68.8)
 Basal 20 (30.3) 10 (31.3)
Luminal B vs. HER2 (N = 291) 0.196
 Luminal B 93 (64.1) 104 (71.2)
 HER2 52 (35.9) 42 (28.8)
Luminal B vs. Basal (N = 227) 0.047
 Luminal B 93 (82.3) 104 (91.2)
 Basal 20 (17.7) 10 (8.8)
HER2 vs. Basal (N = 124) 0.273
 HER2 52 (72.2) 42 (80.8)
 Basal 20 (27.8) 10 (19.2)